Karnitz, Larry M <br/><br/>
Gemcitabine-induced activation of checkpoint signaling pathways that affect tumor cell survival.  [electronic resource] 

 -  Molecular pharmacology  Dec 2005 
 - 1636-44 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0026-895X 
<br/><br/><label>Standard No.: </label>10.1124/mol.105.012716  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Ataxia Telangiectasia Mutated Proteins<br/>Cell Cycle Proteins--drug effects<br/>Cell Line, Tumor<br/>Cell Survival<br/>Checkpoint Kinase 1<br/>Checkpoint Kinase 2<br/>Cytarabine--pharmacology<br/>DNA-Binding Proteins--metabolism<br/>Deoxycytidine--analogs & derivatives<br/>Dose-Response Relationship, Drug<br/>Humans<br/>Protein Kinases--metabolism<br/>Protein Serine-Threonine Kinases--metabolism<br/>Signal Transduction--drug effects<br/>Tumor Suppressor Proteins--metabolism<br/>Gemcitabine